Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Cush

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Rationale and risks of novel immunomodulatory therapies in rheumatoid arthritisJ J Cush
Annals of the Rheumatic Diseases|October 22, 2005
Biological drug use: US perspectives on indications and monitoringJ J Cush
Clinical and Experimental Rheumatology|February 19, 2004
Early arthritis clinic: a USA perspectiveJ J Cush
Bulletin on the Rheumatic Diseases|December 2, 2000
Adult-onset Still's diseaseJ J Cush
Clinical and Experimental Rheumatology|November 24, 2004
Unusual toxicities with TNF inhibition: heart failure and drug-induced lupusJ J Cush
Clinical and Experimental Rheumatology|November 9, 2005
Laboratory monitoring of biologic therapiesJ J Cush, Y Yazici
Rheumatic Diseases Clinics of North America|August 1, 1995
Biologic interventions in rheumatoid arthritisJ J Cush, A F Kavanaugh
Clinical Orthopaedics and Related Research|April 1, 1991
Cellular basis for rheumatoid inflammationJ J Cush, P E Lipsky
Arthritis and Rheumatism|October 1, 1988
Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritisJ J Cush, P E Lipsky
The American Journal of the Medical Sciences|July 1, 1985
Drug-induced lupus: clinical spectrum and pathogenesisJ J Cush, E A Goldings
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Rationale and risks of novel immunomodulatory therapies in rheumatoid arthritisJ J Cush
Annals of the Rheumatic Diseases|October 22, 2005
Biological drug use: US perspectives on indications and monitoringJ J Cush
Clinical and Experimental Rheumatology|February 19, 2004
Early arthritis clinic: a USA perspectiveJ J Cush
Bulletin on the Rheumatic Diseases|December 2, 2000
Adult-onset Still's diseaseJ J Cush
Clinical and Experimental Rheumatology|November 24, 2004
Unusual toxicities with TNF inhibition: heart failure and drug-induced lupusJ J Cush
Clinical and Experimental Rheumatology|November 9, 2005
Laboratory monitoring of biologic therapiesJ J Cush, Y Yazici
Rheumatic Diseases Clinics of North America|August 1, 1995
Biologic interventions in rheumatoid arthritisJ J Cush, A F Kavanaugh
Clinical Orthopaedics and Related Research|April 1, 1991
Cellular basis for rheumatoid inflammationJ J Cush, P E Lipsky
Arthritis and Rheumatism|October 1, 1988
Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritisJ J Cush, P E Lipsky
The American Journal of the Medical Sciences|July 1, 1985
Drug-induced lupus: clinical spectrum and pathogenesisJ J Cush, E A Goldings
Pageof 4